The Journal of Nutritional Biochemistry
Volume 21, Issue 10 , Pages 906-913 , October 2010

Carrageenan-induced innate immune response is modified by enzymes that hydrolyze distinct galactosidic bonds

  • Sumit Bhattacharyya

      Affiliations

    • Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA
    • Jesse Brown VA Medical Center, Chicago, IL 60612, USA
    • ,
  • Haiying Liu

      Affiliations

    • Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY, USA
    • ,
  • Zhenqing Zhang

      Affiliations

    • Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY, USA
    • ,
  • Murielle Jam

      Affiliations

    • UPMC Univ Paris 06, UMR 7139 Marine Plants and Biomolecules, Station Biologique de Roscoff, F-29682 Roscoff, Bretagne, France
    • CNRS, UMR 7139 Marine Plants and Biomolecules, Station Biologique de Roscoff, F-29682 Roscoff, Bretagne, France
    • ,
  • Pradeep K. Dudeja

      Affiliations

    • Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA
    • Jesse Brown VA Medical Center, Chicago, IL 60612, USA
    • ,
  • Gurvan Michel

      Affiliations

    • UPMC Univ Paris 06, UMR 7139 Marine Plants and Biomolecules, Station Biologique de Roscoff, F-29682 Roscoff, Bretagne, France
    • CNRS, UMR 7139 Marine Plants and Biomolecules, Station Biologique de Roscoff, F-29682 Roscoff, Bretagne, France
    • ,
  • Robert J. Linhardt

      Affiliations

    • Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY, USA
    • ,
  • Joanne K. Tobacman

      Affiliations

    • Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA
    • Jesse Brown VA Medical Center, Chicago, IL 60612, USA
    • Corresponding Author InformationCorresponding author. Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA. Tel.: +1 312 569 7826 63; fax: +1 312 413 8283.

Received 13 April 2009 ,Revised 26 June 2009 ,Accepted 2 July 2009.

References 

  1. Imeson AP. Carrageenan, chapter 5. In:  Phillips GO,  Williams PO editor. Handbook of hydrocolloids. Cambridge (England): Woodhead Publishing Limited; 2000;p. 87–102
  2. Tobacman JK. Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ Health Perspect. 2001;109:983–994
  3. Somogyi LP, Miller S, Kishi A. In: Food additives. San Francisco (Calif): Specialty Chemicals, SRI Consulting; 2005;p. 2005
  4. Tobacman JK, Wallace R, Zimmerman B. Consumption of carrageenan and other water-soluble polymers used as food additives and incidence of mammary carcinoma in the United States in the twentieth century. Med Hypotheses. 2001;56:589–598
  5. Marinalg Working Group on Molecular Weight Determination. Technical position on measurements related to meeting the EC molecular weight distribution specification for carrageenan and PEC. www.marinalg.org/papers/papers-inf.htm2006;
  6. Marrs WM. The stability of carrageenan to processing. In:  Williams PA,  Phillips GO editor. Gums and stabilizers for the food industry. Cambridge (England): The Royal Society of Chemistry; 1998;
  7. Michel G, Nyval-Collen P, Barbeyron T, Czjzek M, Helbert W. Bioconversion of red seaweed galactans: a focus on bacterial agarases and carrageenases. Appl Microbiol Biotechnol. 2006;71:23–33
  8. Rees D. Structure, conformation, and mechanism in the formation of polysaccharide gels and networks. Adv Carbohydr Chem Biochem. 1969;24:267–332
  9. Knutsen S, Myslabodski D, Larsen B, Usov A. A modified system of nomenclature for red algal galactans. Botany. 1994;37:163–169
  10. Guibet M, Kervarec N, Genicot S, Chevolot Y, Helbert W. Complete assignment of (1)H and (13)C NMR spectra of Gigartina skottsbergii lambda-carrageenan using carrabiose oligosaccharides prepared by enzymatic hydrolysis. Carbohydr Res. 2006;341:1859–1869
  11. Baumann BC, Stussi G, Huggel K, Rieben R, Seebach JD. Reactivity of human natural antibodies to endothelial cells from Galpha(1,3)Gal-deficient pigs. Transplantation. 2007;83:193–201
  12. Galili U. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol Cell Biol. 2005;83:674–686
  13. Sandrin MS, Osman N, McKenzie IF. Transgenic approaches for the reduction in expression of GALα(1,3)GAL for xenotransplantation. Front Biosci. 1997;2:e1–e11
  14. Osman N, McKenzie IF, Ostenried K, Ioannou YA, Desnick RJ, Sandrin MS. Combined transgenic expression of alpha-galactosidase and alpha 1,2 fucosyltransferase leads to optimal reduction in the major xenoepitope Gal-alpha(1,3)Gal. Proc Natl Acad Sci USA. 1997;94:14677–14682
  15. Tanemura M, Yin D, Chong AS, Galili U. Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J Clin Invest. 2000;105:301–310
  16. Borthakur A, Bhattacharyya S, Dudeja PK, Tobacman JK. Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2007;292:G829–G838
  17. Bhattacharyya S, Gill R, Chen ML, Zhang F, Linhardt RJ, Dudeja PK, et al. Toll-like receptor 4 mediates induction of Bcl10–NFκB–IL-8 inflammatory pathway by carrageenan in human intestinal epithelial cells. J Biol Chem. 2008;283:10550–10558
  18. Bhattacharyya S, Dudeja PK, Tobacman JK. Carrageenan-induced NFκB activation depends on distinct pathways mediated by reactive oxygen species and Hsp27 or by Bcl10. Biochim Biophys Acta. 2008;1780:973–982
  19. Zhou H, Wertz I, O'Rourke K, Ultsch M, Seshagiri S, Eby M, et al. Bcl10 activates the NFκB pathway through ubiquitination of NEMO. Nature. 2004;427:167–171
  20. Drew D, Shimada E, Huynh K, Bergqvist S, Talwar R, Karin M, et al. Inhibitor kappaB kinase beta binding by inhibitor kappaB kinase gamma. Biochemistry. 2007;46:12482–12490
  21. Moyer MP, Manzano LA, Merriman RL, Stauffer JS, Tanzer LR. NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell Dev Biol Anim. 1996;32:315–317
  22. Yu G, Guan H, Ioanoviciu AS, Sikkander SA, Thanawiroon C, Tobacman JK, et al. Structural studies on κ-CGN derived oligosaccharides. Carbohydr Res. 2002;337:433–440
  23. Michel G, Chantalat L, Fanchon E, Henrissat B, Kloareg B, Dideberg O. The iota-carrageenase of Alteromonas fortis. A beta-helix fold-containing enzyme for the degradation of a highly polyanionic polysaccharide. J Biol Chem. 2001;276:40202–40209
  24. Michel G, Chantalat L, Duee E, Barbeyron T, Henrissat B, Kloareg B, et al. The kappa-carrageenase of P. carrageenovora features a tunnel-shaped active site: a novel insight in the evolution of Clan-B glycoside hydrolases. Structure. 2001;9:513–525
  25. Guibet M, Colin S, Barbeyron T, Genicot S, Kloareg B, Michel G, et al. Degradation of lambda-carrageenan by Pseudoalteromonas carrageenovora lambda-carrageenase: a new family of glycoside hydrolases unrelated to kappa- and iota-carrageenases. Biochem J. 2007;404:105–114
  26. Bhattacharyya S, Pant N, Dudeja , Tobacman JK. Development, evaluation, and application of a highly sensitive microtiter plate ELISA for human Bcl10 protein. J Immunoassay Immunochem. 2007;28:173–188
  27. Ndengele MM, Muscoli C, Wang ZQ, Doyle TM, Matuschak GM, Salvemini D. Superoxide potentiates NF-kappaB activation and modulates endotoxin-induced cytokine production in alveolar macrophages. Shock. 2005;23:186–193
  28. Spagnuolo PA, Dalgleish DG, Goff HD, Morris ER. Kappa-carrageenan interactions in systems containing casein micelles and polysaccharide stabilizers. Food Hydrocolloids. 2005;19:371–377
  29. Mottet KN. Carrageenan ulceration as a model for human ulcerative colitis. Lancet. 1970;2:1361
  30. Moyana TN, Lalonde JM. Carrageenan-induced intestinal injury in the rat — a model for inflammatory bowel disease. Ann Clin Lab Sci. 1990;20:420–426
  31. Onderdonk AB. The carrageenan model for experimental ulcerative colitis. Prog Clin Biol Res. 1985;186:237–245
  32. Oohashi Y, Ishioka TT, Wakabayashi K, Kuwabara H. A study of carcinogenesis induced by degraded carrageenan arising from squamous metaplasia of the rat colorectum. Cancer Lett. 1981;14:267–272
  33. Zhang Q, Siebert R, Yan M, Hinzmann B, Cui X, Xue L, et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet. 1999;22:63–68
  34. Willis TG, Jadayel DM, Du MQ, Peng H, Perry AR, Abdul-Rauf M, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell. 1999;96:46–56
  35. Bhattacharyya S, Borthakur A, Dudeja PK, Tobacman JK. Carrageenan reduces bone morphogenetic protein-4 (BMP4) and activates Wnt/β-catenin pathway in normal human colonic epithelial cells. Dig Dis Sci. 2007;52:2766–2774
  36. Bhattacharyya S, Borthakur A, Dudeja PK, Tobacman JK. Carrageenan induces cell cycle arrest in human intestinal epithelial cells in vitro. J Nutr. 2008;138:469–475
  37. Feng L, Han W, Wang Q, Bastin D, Wang L. Characterization of Escherichia coli O86 O-antigen gene cluster and identification of O86-specific genes. Vet Microbiol. 2005;106:241–248
  38. Stenutz R, Weintraub A, Widmalm G. The structures of Escherichia coli O-polysaccharide antigens. FEMS Microbiol Rev. 2006;30:382–403
  39. http://www.casper.organ.su.se/ECODAB/.
  40. Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, Morse M, et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med. 2008;358:1109–1117
  41. Kim HM, Park BS, Kim JI, Kim SE, Lee J, Oh SC, et al. Crystal structure of the TLR4–MD-2 complex with bound endotoxin antagonist eritoran. Cell. 2007;130(5):906–917

PII: S0955-2863(09)00152-1

doi: 10.1016/j.jnutbio.2009.07.002

The Journal of Nutritional Biochemistry
Volume 21, Issue 10 , Pages 906-913 , October 2010

Article Tools

* Image Usage & Resolution